Durable Efficacy and Safety of Raltegravir Versus Efavirenz When Combined With Tenofovir/Emtricitabine in Treatment-Naive HIV-1–Infected Patients : Final 5-Year Results From STARTMRK
| dc.contributor.author | Rockstroh, Jürgen K. | |
| dc.contributor.author | DeJesus, Edwin | |
| dc.contributor.author | Lennox, Jeffrey L. | |
| dc.date.accessioned | 2020-09-10T23:42:28Z | |
| dc.date.accessioned | 2023-05-11T17:04:29Z | |
| dc.date.available | 2020-09-10T23:42:28Z | |
| dc.date.available | 2023-05-11T17:04:29Z | |
| dc.date.created | 2013-05 | |
| dc.identifier | https://journals.lww.com/jaids/Fulltext/2013/05010/Durable_Efficacy_and_Safety_of_Raltegravir_Versus.11.aspx | spa |
| dc.identifier.issn | 1525-4135 / 1944-7884 (Electrónico) | spa |
| dc.identifier.uri | https://hdl.handle.net/20.500.12032/103481 | |
| dc.format | spa | |
| dc.format.mimetype | application/pdf | spa |
| dc.language | Inglés | spa |
| dc.rights.uri | http://creativecommons.org/licenses/by-nc/4.0/ | * |
| dc.source | Journal of Acquired Immune Deficiency Syndromes; Vol. 63 Núm. 1 (2013) | spa |
| dc.title | Durable Efficacy and Safety of Raltegravir Versus Efavirenz When Combined With Tenofovir/Emtricitabine in Treatment-Naive HIV-1–Infected Patients : Final 5-Year Results From STARTMRK | spa |
| dc.type | info:eu-repo/semantics/article |
Files in this item
| Files | Size | Format | View |
|---|---|---|---|
| Durable_Efficac ... _Raltegravir_Versus.11.pdf | 601.7Kb | application/pdf | View/ |
This item appears in the following Collection(s)
Except where otherwise noted, this item's license is described as http://creativecommons.org/licenses/by-nc/4.0/